Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Brooks Hill Partners is a venture capital firm specializing in life sciences and early-stage health tech investments. Founded in 2018 and based in Waltham, Massachusetts, the firm has established itself as a key player in the healthcare technology sector. The firm partners with a diverse range of clients, from large corporations to startups, emphasizing the integration of healthcare and technology.
With a focus on providing critical support during the development, pre-commercial, and growth stages of its portfolio companies, Brooks Hill Partners has cultivated a strong reputation for its customized, data-driven strategies. The firm currently manages a portfolio of 12 companies, reflecting its commitment to enhancing operational capabilities and market positioning for its clients.
Brooks Hill Partners operates from its headquarters in Waltham, Massachusetts, and has made significant strides since its inception. The firm’s hybrid model of combining strategy consulting with seed-stage investments allows it to inform its investment strategy through advisory work, creating a flywheel effect where consulting clients become potential deal flow.
Brooks Hill Partners invests primarily in life sciences and health tech companies, targeting various stages of development including pre-seed, seed, seed-plus, Series A, Series B, and growth equity. The firm emphasizes customized solutions tailored to the specific needs of its portfolio companies, leveraging data-driven strategies to enhance organizational capabilities and capitalize on market opportunities.
The firm’s investment thesis centers on the intersection of healthcare and technology, where it seeks to identify innovative solutions that address pressing healthcare challenges. Brooks Hill Partners looks for founders who demonstrate a strong vision, a deep understanding of their market, and the ability to execute their business plans effectively. The firm’s geographic focus is primarily on North America, allowing it to tap into a rich pool of innovative startups and established companies.
Brooks Hill Partners has built a notable portfolio of 12 companies, each contributing to advancements in healthcare and technology. Key portfolio companies include:
Dane Callow: Founder & Managing Partner. Dane has extensive experience in venture capital and healthcare, having led numerous investments in innovative health tech companies. He holds a degree in Biomedical Engineering from a top university.
Elizabeth Welch: Senior Associate. Elizabeth specializes in market analysis and due diligence, bringing a strong background in healthcare consulting to the firm. She has previously worked with leading healthcare organizations.
Piper Boss: Associate. Piper focuses on sourcing new investment opportunities and supporting portfolio companies. She has a background in life sciences and holds a degree in Biology.
Federico Somaini: Associate. Federico has experience in financial modeling and investment analysis, contributing to the firm's decision-making processes. He holds an MBA from a prestigious institution.
Liam Boyd: Senior Consultant. Liam provides strategic insights and operational support to portfolio companies, leveraging his background in healthcare management.
Shawn Tjahaja: Senior Associate. Shawn specializes in technology investments, particularly in AI and digital health. He has a strong technical background and experience in startup environments.
Abdul Abubakari: Associate. Abdul focuses on market research and competitive analysis, helping to identify promising investment opportunities in the health tech sector.
To pitch Brooks Hill Partners, founders should send an email to info@brookshillpartners.com. The pitch deck should include an overview of the business model, market analysis, competitive landscape, and team background. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In 2023, Brooks Hill Partners made several notable investments in innovative health tech startups, further expanding its portfolio. The firm has been particularly active in sectors leveraging advanced technologies such as AI and 3D bioprinting.
On March 15, 2023, Brooks Hill Partners announced its investment in **DEEP 6 AI**, a company utilizing AI for faster patient recruitment in clinical trials. This investment aligns with the firm's focus on enhancing operational efficiencies in healthcare.
Additionally, Brooks Hill Partners has been recognized for its contributions to the health tech sector, participating in industry conferences and panels to discuss the future of healthcare innovation.
What are Brooks Hill Partners' investment criteria?
Brooks Hill Partners focuses on life sciences and health tech companies at various stages, including pre-seed, seed, Series A, and growth equity. The firm seeks innovative solutions that address significant healthcare challenges.
How can I apply or pitch to Brooks Hill Partners?
Founders can reach out via email at info@brookshillpartners.com to discuss potential investment opportunities. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
What makes Brooks Hill Partners different from other venture capital firms?
The firm combines venture capital with strategy consulting, allowing it to provide tailored support to its portfolio companies. This hybrid model creates a unique synergy where advisory work informs investment decisions.
What is the geographic scope of Brooks Hill Partners' investments?
Brooks Hill Partners primarily invests in North America, focusing on innovative startups and established companies within the healthcare and technology sectors.
What type of post-investment involvement does Brooks Hill Partners have?
The firm actively supports its portfolio companies through various stages of development, providing operational guidance and strategic insights to enhance growth and market positioning.
What is the typical check size for investments made by Brooks Hill Partners?
While specific check sizes are not disclosed, the firm invests across multiple stages, indicating a flexible approach to funding based on the needs of the portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.